These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1643020)

  • 1. Mutations of the p53 tumour suppressor gene in haematologic neoplasms.
    Mori N; Wada M; Yokota J; Terada M; Okada M; Teramura M; Masuda M; Hoshino S; Motoji T; Oshimi K
    Br J Haematol; 1992 Jun; 81(2):235-40. PubMed ID: 1643020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.
    Mori N; Hidai H; Yokota J; Okada M; Motoji T; Oshimi K; Mizoguchi H
    Leuk Res; 1995 Nov; 19(11):869-75. PubMed ID: 8551805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
    Gaidano G; Serra A; Guerrasio A; Rege-Cambrin G; Mazza U; Saglio G
    Ann Hematol; 1994 Jan; 68(1):3-7. PubMed ID: 8110876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the p53 gene in myelodysplastic syndromes.
    Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
    Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutation in the myelodysplastic syndromes.
    Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE
    Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of refractory anaemia with p53 point mutation at codon 249 (AGG to ATG).
    Kikukawa M; Aoki N; Mori M
    Br J Haematol; 1996 Mar; 92(4):831-3. PubMed ID: 8616074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
    Aggerholm A; Grønbaek K; Guldberg P; Hokland P
    Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 gene mutations in acute myelogenous leukaemia.
    Hu G; Zhang W; Deisseroth AB
    Br J Haematol; 1992 Aug; 81(4):489-94. PubMed ID: 1390233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan.
    Kondo K; Umemoto A; Akimoto S; Uyama T; Hayashi K; Ohnishi Y; Monden Y
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1139-46. PubMed ID: 1348931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
    Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
    Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and RAS gene mutations in multiple myeloma.
    Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
    Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of p53 gene mutations in acute myeloid leukemia.
    Trecca D; Longo L; Biondi A; Cro L; Calori R; Grignani F; Maiolo AT; Pelicci PG; Neri A
    Am J Hematol; 1994 Aug; 46(4):304-9. PubMed ID: 8037181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.